Viewing nowSec Capsule (Cefaclor Hydrate)
Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Optus Pharmaceutical Co., Ltd.

MFDS item code 200705133 · Notified 2007.05.03 · Insurance code 674100130
Treatment of otitis media, respiratory infections (such as pneumonia, pharyngitis), and urinary tract infections (such as pyelonephritis, cystitis)
This medication is effective against various harmful bacteria, including Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus, Group A beta-hemolytic Streptococcus, and Escherichia coli. It is mainly used for the treatment of respiratory infections like otitis media, pneumonia, pharyngitis, tonsillitis, and bronchitis. It is also effective for urinary tract infections such as pyelonephritis, cystitis, and gonococcal urethritis. Additionally, it is used for treating skin and soft tissue infections such as abscesses, furuncles, folliculitis, soft tissue infections, infectious gangrene, subcutaneous abscesses, ingrown nails, and wound infections. This drug helps improve various infectious diseases.
Administer 250 mg (potency) of cefaclor hydrate orally every 8 hours. For severe infections (such as pneumonia) and infections with low susceptibility, the dose may be doubled. In cases of acute gonococcal urethritis, 3 g of this medication and 1 g of probenecid should be administered together as a single dose.
Administer 20 mg/kg (potency) by weight divided every 8 hours. For cases of severe infection, otitis media, and infections with low susceptibility, a dose of 40 mg/kg (potency) may be administered, with a maximum dose of
This medication is an antibiotic that kills bacteria by binding to specific proteins and inhibiting bacterial cell wall synthesis. This drug must not be administered to patients who have experienced severe allergic reactions or shock from this medication or similar antibiotics in the past. Additionally, caution should be exercised in patients with allergies to penicillin antibiotics or those prone to asthma, rash, or hives. Patients with severely impaired kidney function, those who have difficulty swallowing, elderly patients, and those with a history of gastrointestinal diseases also need to be cautious. While using this drug, it is important to closely monitor for symptoms such as shock, allergic reactions, skin rashes, blood abnormalities, liver and kidney dysfunction, gastrointestinal issues, respiratory issues, and central nervous system symptoms. In particular, there may be rare cases of serious skin diseases or blood disorders, so if any unusual symptoms occur, administration should be stopped immediately and medical attention sought. It is important to administer this medication for the appropriate duration determined by susceptibility tests to prevent the development of resistant bacteria. When used with other medications, there may be interactions, particularly with drugs that can affect the kidneys, anticoagulants, and oral contraceptives. Women who are pregnant or breastfeeding should use this medication cautiously, as its safety has not been fully established; medical consultation is recommended if necessary. It is advisable not to use this medication for newborns less than one month old, as its safety and efficacy have not been established. Elderly patients may experience adverse reactions more readily due to decreased bodily function, so careful monitoring of dosage and administration intervals is required. This medication may affect certain clinical test results, so this should be taken into account during examinations.
Shock, anaphylactic symptoms (generalized redness, swelling, difficulty breathing, angioedema, sensory disturbances, fainting, hypertension, vasodilation), Stevens-Johnson syndrome, toxic epidermal necrolysis, agranulocytosis, granulocytopenia, pancytopenia, anemia, thrombocytopenia, aplastic anemia, hemolytic anemia, reversible neutropenia, transient hepatitis, jaundice, elevated AST, ALT, ALP, reversible interstitial nephritis, elevated BUN, serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light. Also, it is best to store the medication at room temperature between 1°C and 30°C. Storing it this way will help maintain its effectiveness for a long time.
Hard capsules filled with crystalline powder that is white or yellowish-white, with an orange upper and white lower part.
30 capsules/bottle, 300 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCefaclor Hydrate 250mg
Hard capsule · Prescription medication
Optus Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Kolon Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 2.5g
Syrup · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.